Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters
The modified trivalent live attenuated influenza vaccine encoding the T-cell epitopes of SARS-CoV-2 can be considered a promising tool for combined protection against seasonal influenza and COVID-19.
Authors
- Ekaterina Bazhenova (ORCID: https://orcid.org/0000-0003-3280-556X)
- Daria А. Mezhenskaya (ORCID: https://orcid.org/0000-0001-6922-7682)
- Polina Prokopenko (ORCID: https://orcid.org/0000-0002-7247-979X)
- K. L. Kryshen (ORCID: https://orcid.org/0000-0003-1451-7716)
- Kristina N. Rodionova (ORCID: https://orcid.org/0000-0001-6187-2097)
- Alexandra Rak (ORCID: https://orcid.org/0000-0001-5552-9874)
- Ekaterina Stepanova (ORCID: https://orcid.org/0000-0002-8670-8645)
- Irina Isakova–Sivak (ORCID: https://orcid.org/0000-0002-2801-1508)
- Arina D. Kostromitina (ORCID: https://orcid.org/0000-0001-5432-0171)
- К. В. Сивак (ORCID: https://orcid.org/0000-0003-4064-5033)
- Valery Makarov
- Larisa Rudenko (ORCID: https://orcid.org/0000-0002-0107-9959)
- Tatiana Kotomina (ORCID: https://orcid.org/0000-0001-9999-089X)
- Svetlana Donina (ORCID: https://orcid.org/0000-0002-6502-8341)
- Anna Chistiakova (ORCID: https://orcid.org/0000-0001-9541-5636)
- Victoria Matyushenko (ORCID: https://orcid.org/0000-0002-4698-6085)
- Vlada Novitskaya
Institutions
- Institute of Experimental Medicine (RU)
- Research Institute of Influenza (RU)
Publication Details
- Journal
- Vaccines
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3390/vaccines12121300
- Citations
- 4
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Russian Science Foundation